Healthcare Innovations II, 1

Back to All Secondary Trusts
SymbolSTHCAX
Term2 Year
Prospectus
Fact Card
The trust seeks total return potential primarily through capital appreciation. Income may also contribute to the trust’s total return but little, if any, income is anticipated. There is no guarantee that the investment objectives of the trust will be achieved.

  • Description

    • Status Secondary
    • Category Equity Oriented Portfolio
    • Objective NA

  • Pricing (09-18-2024)

    • Bid Price $10.7498
    • Liquidation Price $10.7498

  • Deposit Data

    • Deposit Date 05-04-2023
    • Termination Date 05-01-2025
    • Initial Offer Price $10.00
    • Max Sales Charge 2.75%

  • CUSIPs

    • Cash 83207C712
    • Reinvest 83207C720
    • Fee - Cash 83207C738
    • Fee - Reinvest 83207C746

  • Historical 12-Month Distribution*

    • Pay FrequencyMonthly (if any)
    • Historical 12-Month Distribution*0.00

  • Sector Breakdown (As of Deposit Date)

  • Pricing Summary (As of 09-18-2024)

*The Historical 12-Month Distribution of Trust Holdings is as of 04/01/2024. If the Trust deposited after, or 90 days prior to, 04/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.